BLOCKADE BY SIGMA-SITE LIGANDS OF HIGH VOLTAGE-ACTIVATED CA2+ CHANNELS IN RAT AND MOUSE CULTURED HIPPOCAMPAL PYRAMIDAL NEURONS

被引:50
作者
CHURCH, J [1 ]
FLETCHER, EJ [1 ]
机构
[1] UNIV TORONTO,DEPT PHYSIOL,TORONTO,ON M5S 1A8,CANADA
关键词
CULTURED HIPPOCAMPAL PYRAMIDAL NEURONS; A RECEPTORS; VOLTAGE-ACTIVATED CA2+ CHANNELS;
D O I
10.1111/j.1476-5381.1995.tb15929.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effects of a series of structurally-dissimilar sigma site ligands were examined on high voltage-activated Ca2+ channel activity in two preparations of cultured hippocampal pyramidal neurones. 2 In mouse hippocampal neurones under whole-cell voltage-clamp, voltage-activated Ca2+ channel currents carried by barium ions (I-Ba) were reduced with the rank order (IC50 values in mu M): 1S,2R-(-)-cis-N-methyl-N-[2-(3,4-dichlorophenyl)ethyl]-2- (1-pyrrolidinyl)cyclohexylamine (7.8)>rimcazole (13)> haloperidol (16)>ifenprodil (18)>opipramol (32)>carbetapentane (40)=1-benzylspiro[1,2,3,4-tetrahydronaphthalene-1,4-piperidine] (42)>caramiphen (47)>dextromethorphan (73). At the highest concentrations tested, the compounds almost abolished I-Ba in the absence of any other pharmacological agent. 3 The current-voltage characteristics of the whole-cell I-Ba were unaffected by the test compounds. The drug-induced block was rapid in onset and offset, with the exceptions of carbetapentane and caramiphen where full block was achieved only after two to three voltage-activated currents and was associated with an apparent increase in the rate of inactivation of I-Ba. 4 In rat hippocampal neurones loaded with the Ca2+-sensitive dye Fura-2, rises in intracellular free Ca2+ concentration evoked by transient exposure to 50 mM K+-containing medium, either in the absence or in the presence of 10 mu M nifedipine (to block L-type high voltage-activated Ca2+ channels), were also reversibly attenuated by the sigma ligands. The rank order potencies for the compounds in these experimental paradigms were similar to that observed for blockade of I-Ba in the electrophysiological studies. 5 These results indicate that, at micromolar concentrations, the compounds tested block multiple subtypes of high voltage-activated Ca2+ channels. These actions, which do not appear to be mediated by high-affinity sigma binding sites, may play a role in some of the functional effects previously described for the compounds.
引用
收藏
页码:2801 / 2810
页数:10
相关论文
共 48 条
[1]   NONOPIOID ANTITUSSIVES INHIBIT ENDOGENOUS GLUTAMATE RELEASE FROM RABBIT HIPPOCAMPAL SLICES [J].
ANNELS, SJ ;
ELLIS, Y ;
DAVIES, JA .
BRAIN RESEARCH, 1991, 564 (02) :341-343
[2]   EFFECTS OF NONOPIOID ANTITUSSIVES ON EPILEPTIFORM ACTIVITY AND NMDA RESPONSES IN HIPPOCAMPAL AND OLFACTORY CORTEX SLICES [J].
APLAND, JP ;
BRAITMAN, DJ .
BRAIN RESEARCH, 1990, 529 (1-2) :277-285
[3]  
ARAM JA, 1989, J PHARMACOL EXP THER, V248, P320
[4]   PHARMACOLOGICAL COMPARISON OF THE SIGMA RECOGNITION SITE LABELED BY [3H]HALOPERIDOL IN HUMAN AND RAT CEREBELLUM [J].
BARNES, JM ;
BARNES, NM ;
BARBER, PC ;
CHAMPANERIA, S ;
COSTALL, B ;
HORNSBY, CD ;
IRONSIDE, JW ;
NAYLOR, RJ .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1992, 345 (02) :197-202
[5]   REGULATION OF SIGMA-RECEPTORS - HIGH-AFFINITY AND LOW-AFFINITY AGONIST STATES, GTP SHIFTS, AND UP-REGULATION BY RIMCAZOLE AND 1,3-DI(2-TOLYL)GUANIDINE [J].
BEART, PM ;
OSHEA, RD ;
MANALLACK, DT .
JOURNAL OF NEUROCHEMISTRY, 1989, 53 (03) :779-788
[6]   SB-201823-A, A NEURONAL CA2+ ANTAGONIST IS NEUROPROTECTIVE IN 2 MODELS OF CEREBRAL-ISCHEMIA [J].
BENHAM, CD ;
BROWN, TH ;
COOPER, DG ;
EVANS, ML ;
HARRIES, MH ;
HERDON, HJ ;
MEAKIN, JE ;
MURKITT, KL ;
PATEL, SR ;
ROBERTS, JC ;
ROTHAUL, AL ;
SMITH, SJ ;
WOOD, N ;
HUNTER, AJ .
NEUROPHARMACOLOGY, 1993, 32 (11) :1249-1257
[7]   THE NMDA RECEPTOR ANTAGONIST ELIPRODIL (SL-82.0715) BLOCKS VOLTAGE-OPERATED CA2+ CHANNELS IN RAT CULTURED CORTICAL-NEURONS [J].
BITON, B ;
GRANGER, P ;
CARREAU, A ;
DEPOORTERE, H ;
SCATTON, B ;
AVENET, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 257 (03) :297-301
[8]  
BURKE SP, 1993, EUR J PHARMACOL, V283, P383
[9]   [H-3] (+)-PENTAZOCINE BINDING TO RAT-BRAIN SIGMA(1) RECEPTORS [J].
CAGNOTTO, A ;
BASTONE, A ;
MENNINI, T .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 266 (02) :131-138
[10]  
CHURCH J, 1994, MOL PHARMACOL, V45, P747